{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:19:16Z","timestamp":1790104756883,"version":"4.0.1"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple sclerosis (MS) is an autoimmune neuroinflammatory disease resulting in myelin degeneration and progressive disability. Oxidative stress plays a crucial role in MS pathogenesis and progression. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a master regulator of the antioxidant mechanisms and its upregulation is associated with beneficial effects in MS. Among the environmental factors influencing MS onset and progression, diet represents a promising non-pharmacological strategy to modulate Nrf2, potentially improving MS outcomes. Indeed, several natural compounds present in Mediterranean, ketogenic and Paleolithic diets can enhance Nrf2 activity, and exert beneficial effects in preclinical models of MS. In this review, we summarize the key role of oxidative stress in MS and highlight how dietary regimens and Nrf2-modulating natural compounds might have therapeutic potential for MS patients. Additionally, we discuss emerging and still poorly explored mechanisms beyond classical Nrf2 activation, including epigenetic regulation and the stability of DNA\/RNA secondary structures known as G-quadruplexes, which are involved in gene expression regulation and may represent novel nutrition-based therapeutic targets. However, while Nrf2 modulation by diet is supported by preclinical and limited clinical evidence, targeting G-quadruplexes as a strategy to counteract oxidative stress in MS remains largely speculative and requires further investigation. Notably, epigenetic mechanisms and G-quadruplexes may represent innovative targets of Nrf2-boosting dietary natural compounds for the development of supplemental therapeutic strategies for MS.<\/jats:p>","DOI":"10.1007\/s12035-026-05748-5","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T03:18:21Z","timestamp":1771384701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Diet\u2013Multiple Sclerosis Connection: Oxidative Stress and Emerging Mechanisms"],"prefix":"10.1007","volume":"63","author":[{"given":"Candida","family":"Bucciero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Beguinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Formisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Portella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ulianich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Fiory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Malfitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"issue":"2","key":"5748_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2174\/1574889810999160719105433","volume":"10","author":"R Ranieri","year":"2016","unstructured":"Ranieri R, Laezza C, Bifulco M, Marasco D, Malfitano AM (2016) Endocannabinoid system in neurological disorders. Recent Pat CNS Drug Discov 10(2):90\u2013112. https:\/\/doi.org\/10.2174\/1574889810999160719105433","journal-title":"Recent Pat CNS Drug Discov"},{"issue":"10422","key":"5748_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Bittner S, Zivadinov R, Morrow SA, Benedict RH, Zipp F, Weinstock-Guttman B (2024) Multiple sclerosis. Lancet (London, England) 403(10422):183\u2013202. https:\/\/doi.org\/10.1016\/s0140-6736(23)01473-3","journal-title":"Lancet (London, England)"},{"issue":"9648","key":"5748_CR3","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/s0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet (London, England) 372(9648):1502\u20131517. https:\/\/doi.org\/10.1016\/s0140-6736(08)61620-7","journal-title":"Lancet (London, England)"},{"issue":"1-2","key":"5748_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jneuroim.2005.09.005","volume":"171","author":"AM Malfitano","year":"2006","unstructured":"Malfitano AM, Matarese G, Pisanti S, Grimaldi C, Laezza C, Bisogno T, Di Marzo V, Lechler RI et al (2006) Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis. J Neuroimmunol 171(1\u20132):110\u2013119. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.09.005","journal-title":"J Neuroimmunol"},{"key":"5748_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/nu11071528","author":"ED Miller","year":"2019","unstructured":"Miller ED, Dziedzic A, Saluk-Bijak J, Bijak M (2019) A review of various antioxidant compounds and their potential utility as complementary therapy in multiple sclerosis. Nutrients. https:\/\/doi.org\/10.3390\/nu11071528","journal-title":"Nutrients"},{"key":"5748_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1973834","volume":"2016","author":"B Adamczyk","year":"2016","unstructured":"Adamczyk B, Adamczyk-Sowa M (2016) New insights into the role of oxidative stress mechanisms in the pathophysiology and treatment of multiple sclerosis. Oxid Med Cell Longev 2016:1973834. https:\/\/doi.org\/10.1155\/2016\/1973834","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"5748_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1191\/1352458505ms1240oa","volume":"11","author":"G Ferretti","year":"2005","unstructured":"Ferretti G, Bacchetti T, Principi F, Di Ludovico F, Viti B, Angeleri VA, Danni M, Provinciali L (2005) Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity. Mult Scler J 11(6):677\u2013682. https:\/\/doi.org\/10.1191\/1352458505ms1240oa","journal-title":"Mult Scler J"},{"issue":"10","key":"5748_CR8","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00204-014-1338-z","volume":"88","author":"JL Lim","year":"2014","unstructured":"Lim JL, Wilhelmus MM, de Vries HE, Drukarch B, Hoozemans JJ, van Horssen J (2014) Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases. Arch Toxicol 88(10):1773\u20131786. https:\/\/doi.org\/10.1007\/s00204-014-1338-z","journal-title":"Arch Toxicol"},{"key":"5748_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/725370","volume":"2015","author":"L Haider","year":"2015","unstructured":"Haider L (2015) Inflammation, iron, energy failure, and oxidative stress in the pathogenesis of multiple sclerosis. Oxid Med Cell Longev 2015:725370. https:\/\/doi.org\/10.1155\/2015\/725370","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"5748_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s12031-020-01672-y","volume":"71","author":"TO Tobore","year":"2021","unstructured":"Tobore TO (2021) Oxidative\/nitroxidative stress and multiple sclerosis. J Mol Neurosci 71(3):506\u2013514. https:\/\/doi.org\/10.1007\/s12031-020-01672-y","journal-title":"J Mol Neurosci"},{"key":"5748_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417223","author":"D Tonev","year":"2023","unstructured":"Tonev D, Momchilova A (2023) Oxidative stress and the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway in multiple sclerosis: focus on certain exogenous and endogenous Nrf2 activators and therapeutic plasma exchange modulation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242417223","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5748_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/toxsci\/kfp274","volume":"114","author":"DA Johnson","year":"2010","unstructured":"Johnson DA, Amirahmadi S, Ward C, Fabry Z, Johnson JA (2010) The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol Sci 114(2):237\u2013246. https:\/\/doi.org\/10.1093\/toxsci\/kfp274","journal-title":"Toxicol Sci"},{"key":"5748_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134777","author":"F He","year":"2020","unstructured":"He F, Ru X, Wen T (2020) NRF2, a transcription factor for stress response and beyond. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21134777","journal-title":"Int J Mol Sci"},{"key":"5748_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.freeradbiomed.2024.09.035","volume":"225","author":"T Wang","year":"2024","unstructured":"Wang T, Liu M, Li X, Zhang S, Gu H, Wei X, Wang X, Xu Z et al (2024) Naturally-derived modulators of the Nrf2 pathway and their roles in the intervention of diseases. Free Radic Biol Med 225:560\u2013580. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.09.035","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"5748_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.biocel.2013.02.012","volume":"45","author":"Q He","year":"2013","unstructured":"He Q, Song N, Jia F, Xu H, Yu X, Xie J, Jiang H (2013) Role of \u03b1-synuclein aggregation and the nuclear factor E2-related factor 2\/heme oxygenase-1 pathway in iron-induced neurotoxicity. Int J Biochem Cell Biol 45(6):1019\u20131030. https:\/\/doi.org\/10.1016\/j.biocel.2013.02.012","journal-title":"Int J Biochem Cell Biol"},{"key":"5748_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.919233","volume":"13","author":"XX Yang","year":"2022","unstructured":"Yang XX, Yang R, Zhang F (2022) Role of Nrf2 in Parkinson\u2019s disease: toward new perspectives. Front Pharmacol 13:919233. https:\/\/doi.org\/10.3389\/fphar.2022.919233","journal-title":"Front Pharmacol"},{"key":"5748_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030549","author":"LM De Plano","year":"2023","unstructured":"De Plano LM, Calabrese G, Rizzo MG, Oddo S, Caccamo A (2023) The role of the transcription factor Nrf2 in Alzheimer\u2019s disease: therapeutic opportunities. Biomolecules. https:\/\/doi.org\/10.3390\/biom13030549","journal-title":"Biomolecules"},{"issue":"8","key":"5748_CR18","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.bbadis.2013.12.011","volume":"1842","author":"L Gan","year":"2014","unstructured":"Gan L, Johnson JA (2014) Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochim Biophys Acta 1842(8):1208\u20131218. https:\/\/doi.org\/10.1016\/j.bbadis.2013.12.011","journal-title":"Biochim Biophys Acta"},{"key":"5748_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179592","author":"E Zgorzynska","year":"2021","unstructured":"Zgorzynska E, Dziedzic B, Walczewska A (2021) An overview of the Nrf2\/ARE pathway and its role in neurodegenerative diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22179592","journal-title":"Int J Mol Sci"},{"key":"5748_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/s1054-3589(08)60993-x","volume":"38","author":"PG Winyard","year":"1997","unstructured":"Winyard PG, Blake DR (1997) Antioxidants, redox-regulated transcription factors, and inflammation. Adv Pharmacol (San Diego, Calif) 38:403\u2013421. https:\/\/doi.org\/10.1016\/s1054-3589(08)60993-x","journal-title":"Adv Pharmacol (San Diego, Calif)"},{"issue":"1\u20132","key":"5748_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/s0165-5728(00)00352-0","volume":"110","author":"HJ Schluesener","year":"2000","unstructured":"Schluesener HJ, Seid K (2000) Heme oxygenase-1 in lesions of rat experimental autoimmune encephalomyelitis and neuritis. J Neuroimmunol 110(1\u20132):114\u2013120. https:\/\/doi.org\/10.1016\/s0165-5728(00)00352-0","journal-title":"J Neuroimmunol"},{"issue":"1-2","key":"5748_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jneuroim.2013.04.013","volume":"261","author":"P Fagone","year":"2013","unstructured":"Fagone P, Patti F, Mangano K, Mammana S, Coco M, Touil-Boukoffa C, Chikovani T, Di Marco R et al (2013) Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis. J Neuroimmunol 261(1\u20132):82\u201386. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.04.013","journal-title":"J Neuroimmunol"},{"issue":"8","key":"5748_CR23","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.freeradbiomed.2010.07.013","volume":"49","author":"J van Horssen","year":"2010","unstructured":"van Horssen J, Drexhage JA, Flor T, Gerritsen W, van der Valk P, de Vries HE (2010) Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic Biol Med 49(8):1283\u20131289. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.07.013","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"5748_CR24","doi-asserted-by":"publisher","first-page":"11783","DOI":"10.3390\/ijms130911783","volume":"13","author":"DH Lee","year":"2012","unstructured":"Lee DH, Gold R, Linker RA (2012) Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters. Int J Mol Sci 13(9):11783\u201311803. https:\/\/doi.org\/10.3390\/ijms130911783","journal-title":"Int J Mol Sci"},{"key":"5748_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12071464","author":"\u00c1 Cores","year":"2023","unstructured":"Cores \u00c1, Carmona-Zafra N, Clerigu\u00e9 J, Villacampa M, Men\u00e9ndez JC (2023) Quinones as neuroprotective agents. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12071464","journal-title":"Antioxidants"},{"issue":"2","key":"5748_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00401-015-1452-x","volume":"130","author":"S Licht-Mayer","year":"2015","unstructured":"Licht-Mayer S, Wimmer I, Traffehn S, Metz I, Br\u00fcck W, Bauer J, Bradl M, Lassmann H (2015) Cell type-specific Nrf2 expression in multiple sclerosis lesions. Acta Neuropathol 130(2):263\u2013277. https:\/\/doi.org\/10.1007\/s00401-015-1452-x","journal-title":"Acta Neuropathol"},{"key":"5748_CR27","first-page":"1503","volume":"22","author":"CM Larabee","year":"2016","unstructured":"Larabee CM, Desai S, Agasing A, Georgescu C, Wren JD, Axtell RC, Plafker SM (2016) Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis. Mol Vis 22:1503\u20131513","journal-title":"Mol Vis"},{"key":"5748_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.593368","volume":"11","author":"Y Yu","year":"2020","unstructured":"Yu Y, Wu DM, Li J, Deng SH, Liu T, Zhang T, He M, Zhao YY et al (2020) Bixin attenuates experimental autoimmune encephalomyelitis by suppressing TXNIP\/NLRP3 inflammasome activity and activating NRF2 signaling. Front Immunol 11:593368. https:\/\/doi.org\/10.3389\/fimmu.2020.593368","journal-title":"Front Immunol"},{"issue":"12","key":"5748_CR29","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/glia.23058","volume":"64","author":"T Draheim","year":"2016","unstructured":"Draheim T, Liessem A, Scheld M, Wilms F, Wei\u00dfflog M, Denecke B, Kensler TW, Zendedel A et al (2016) Activation of the astrocytic Nrf2\/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model. Glia 64(12):2219\u20132230. https:\/\/doi.org\/10.1002\/glia.23058","journal-title":"Glia"},{"key":"5748_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1264842","volume":"14","author":"G Bresciani","year":"2023","unstructured":"Bresciani G, Manai F, Davinelli S, Tucci P, Saso L, Amadio M (2023) Novel potential pharmacological applications of dimethyl fumarate-an overview and update. Front Pharmacol 14:1264842. https:\/\/doi.org\/10.3389\/fphar.2023.1264842","journal-title":"Front Pharmacol"},{"key":"5748_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.172973","volume":"873","author":"D Michali\u010dkov\u00e1","year":"2020","unstructured":"Michali\u010dkov\u00e1 D, Hrn\u010d\u00ed\u0159 T, Canov\u00e1 NK, Slana\u0159 O (2020) Targeting Keap1\/Nrf2\/ARE signaling pathway in multiple sclerosis. Eur J Pharmacol 873:172973. https:\/\/doi.org\/10.1016\/j.ejphar.2020.172973","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"5748_CR32","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1177\/1352458517690617","volume":"23","author":"S Gopal","year":"2017","unstructured":"Gopal S, Mikulskis A, Gold R, Fox RJ, Dawson KT, Amaravadi L (2017) Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies. Multiple Sclerosis (Houndmills, Basingstoke, England) 23(14):1875\u20131883. https:\/\/doi.org\/10.1177\/1352458517690617","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)"},{"issue":"6","key":"5748_CR33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/acn3.553","volume":"5","author":"A Hammer","year":"2018","unstructured":"Hammer A, Waschbisch A, Kuhbandner K, Bayas A, Lee DH, Duscha A, Haghikia A, Gold R et al (2018) The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis. Ann Clin Transl Neurol 5(6):668\u2013676. https:\/\/doi.org\/10.1002\/acn3.553","journal-title":"Ann Clin Transl Neurol"},{"key":"5748_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1347478","volume":"14","author":"TJ Titcomb","year":"2023","unstructured":"Titcomb TJ, Giesser BS, Plafker SM, Katz Sand IB, Wahls TL (2023) Editorial: diet and multiple sclerosis. Front Neurol 14:1347478. https:\/\/doi.org\/10.3389\/fneur.2023.1347478","journal-title":"Front Neurol"},{"issue":"1","key":"5748_CR35","first-page":"1","volume":"67","author":"ML Pall","year":"2015","unstructured":"Pall ML, Levine S (2015) Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanisms, is raised by health promoting factors. Sheng Li Xue Bao: [Acta Physiologica Sinica] 67(1):1\u201318","journal-title":"Sheng Li Xue Bao: [Acta Physiologica Sinica]"},{"issue":"3","key":"5748_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s13668-018-0236-z","volume":"7","author":"I Katz Sand","year":"2018","unstructured":"Katz Sand I (2018) The role of diet in multiple sclerosis: mechanistic connections and current evidence. Curr Nutr Rep 7(3):150\u2013160. https:\/\/doi.org\/10.1007\/s13668-018-0236-z","journal-title":"Curr Nutr Rep"},{"key":"5748_CR37","unstructured":"Daley SF, Challa HJ, Uppaluri KR (2025) Paleolithic diet. In: StatPearls. StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC., Treasure Island (FL),"},{"key":"5748_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neulet.2018.06.016","volume":"683","author":"Y Lu","year":"2018","unstructured":"Lu Y, Yang YY, Zhou MW, Liu N, Xing HY, Liu XX, Li F (2018) Ketogenic diet attenuates oxidative stress and inflammation after spinal cord injury by activating Nrf2 and suppressing the NF-\u03baB signaling pathways. Neurosci Lett 683:13\u201318. https:\/\/doi.org\/10.1016\/j.neulet.2018.06.016","journal-title":"Neurosci Lett"},{"issue":"1","key":"5748_CR39","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.nbd.2010.05.030","volume":"40","author":"JB Milder","year":"2010","unstructured":"Milder JB, Liang LP, Patel M (2010) Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiol Dis 40(1):238\u2013244. https:\/\/doi.org\/10.1016\/j.nbd.2010.05.030","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5748_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02474-2","volume":"19","author":"S Dai","year":"2022","unstructured":"Dai S, Wei J, Zhang H, Luo P, Yang Y, Jiang X, Fei Z, Liang W et al (2022) Intermittent fasting reduces neuroinflammation in intracerebral hemorrhage through the Sirt3\/Nrf2\/HO-1 pathway. J Neuroinflammation 19(1):122. https:\/\/doi.org\/10.1186\/s12974-022-02474-2","journal-title":"J Neuroinflammation"},{"key":"5748_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1677509","volume":"15","author":"E Colombo","year":"2025","unstructured":"Colombo E, Righini M, Balendra V, Rustamli K, Garrone O, Ratti M, Ghidini M (2025) Impact of ketogenic and fast-mimicking diet in gastrointestinal cancer treatment. Front Oncol 15:1677509. https:\/\/doi.org\/10.3389\/fonc.2025.1677509","journal-title":"Front Oncol"},{"key":"5748_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-02035-4","author":"SE Espinoza","year":"2025","unstructured":"Espinoza SE, Park S, Connolly G, Qi W, Zhang N, Semwal M, Li Y, Lauzon M et al (2025) Effect of fasting-mimicking diet on markers of autophagy and metabolic health in human subjects. Geroscience. https:\/\/doi.org\/10.1007\/s11357-025-02035-4","journal-title":"Geroscience"},{"issue":"2","key":"5748_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1542\/pir.2020-004275","volume":"43","author":"E Andrewski","year":"2022","unstructured":"Andrewski E, Cheng K, Vanderpool C (2022) Nutritional deficiencies in vegetarian, gluten-free, and ketogenic diets. Pediatr Rev 43(2):61\u201370. https:\/\/doi.org\/10.1542\/pir.2020-004275","journal-title":"Pediatr Rev"},{"key":"5748_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061844","author":"TJ Titcomb","year":"2020","unstructured":"Titcomb TJ, Bisht B, Moore DD 3rd, Chhonker YS, Murry DJ, Snetselaar LG, Wahls TL (2020) Eating pattern and nutritional risks among people with multiple sclerosis following a modified Paleolithic diet. Nutrients. https:\/\/doi.org\/10.3390\/nu12061844","journal-title":"Nutrients"},{"issue":"38","key":"5748_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx2752","volume":"11","author":"MR Gallop","year":"2025","unstructured":"Gallop MR, Vieira RFL, Mower PD, Matsuzaki ET, Liou W, Smart FE, Roberts S, Evason KJ et al (2025) A long-term ketogenic diet causes hyperlipidemia, liver dysfunction, and glucose intolerance from impaired insulin secretion in mice. Sci Adv 11(38):eadx2752. https:\/\/doi.org\/10.1126\/sciadv.adx2752","journal-title":"Sci Adv"},{"key":"5748_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2012.00084","volume":"3","author":"Z Fonseca-Kelly","year":"2012","unstructured":"Fonseca-Kelly Z, Nassrallah M, Uribe J, Khan RS, Dine K, Dutt M, Shindler KS (2012) Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front Neurol 3:84. https:\/\/doi.org\/10.3389\/fneur.2012.00084","journal-title":"Front Neurol"},{"key":"5748_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118353","volume":"332","author":"F Chi","year":"2024","unstructured":"Chi F, Cheng C, Zhang M, Su B, Hou Y, Bai G (2024) Resveratrol targeting NRF2 disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage in mice pulmonary infection. J Ethnopharmacol 332:118353. https:\/\/doi.org\/10.1016\/j.jep.2024.118353","journal-title":"J Ethnopharmacol"},{"key":"5748_CR48","doi-asserted-by":"publisher","first-page":"8983752","DOI":"10.1155\/2019\/8983752","volume":"2019","author":"D Kong","year":"2019","unstructured":"Kong D, Yan Y, He XY, Yang H, Liang B, Wang J, He Y, Ding Y et al (2019) Effects of resveratrol on the mechanisms of antioxidants and estrogen in Alzheimer\u2019s disease. Biomed Res Int 2019:8983752. https:\/\/doi.org\/10.1155\/2019\/8983752","journal-title":"Biomed Res Int"},{"key":"5748_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2026.119697","volume":"309","author":"Y Ma","year":"2026","unstructured":"Ma Y, Zhang J, Zhou Q, Tang P, Wang X, Zhu H, Huang Z, Su H et al (2026) The activation of SIRT1-Nrf2 axis exerts beneficial effects against rotenone-induced cognitive deficits in mice through inhibition of neuroinflammation and ferroptosis. Ecotoxicol Environ Saf 309:119697. https:\/\/doi.org\/10.1016\/j.ecoenv.2026.119697","journal-title":"Ecotoxicol Environ Saf"},{"key":"5748_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijcard.2021.08.007","volume":"342","author":"JJ Xu","year":"2021","unstructured":"Xu JJ, Cui J, Lin Q, Chen XY, Zhang J, Gao EH, Wei B, Zhao W (2021) Protection of the enhanced Nrf2 deacetylation and its downstream transcriptional activity by SIRT1 in myocardial ischemia\/reperfusion injury. Int J Cardiol 342:82\u201393. https:\/\/doi.org\/10.1016\/j.ijcard.2021.08.007","journal-title":"Int J Cardiol"},{"issue":"2","key":"5748_CR51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11064-017-2421-7","volume":"43","author":"Y Hui","year":"2018","unstructured":"Hui Y, Chengyong T, Cheng L, Haixia H, Yuanda Z, Weihua Y (2018) Resveratrol attenuates the cytotoxicity induced by Amyloid-\u03b2(1\u201342) in PC12 cells by upregulating heme oxygenase-1 via the PI3K\/Akt\/Nrf2 pathway. Neurochem Res 43(2):297\u2013305. https:\/\/doi.org\/10.1007\/s11064-017-2421-7","journal-title":"Neurochem Res"},{"issue":"4","key":"5748_CR52","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.bbrc.2005.03.237","volume":"331","author":"CY Chen","year":"2005","unstructured":"Chen CY, Jang JH, Li MH, Surh YJ (2005) Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 331(4):993\u20131000. https:\/\/doi.org\/10.1016\/j.bbrc.2005.03.237","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"5748_CR53","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/carcin\/20.5.911","volume":"20","author":"AT Dinkova-Kostova","year":"1999","unstructured":"Dinkova-Kostova AT, Talalay P (1999) Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcinogenesis 20(5):911\u2013914. https:\/\/doi.org\/10.1093\/carcin\/20.5.911","journal-title":"Carcinogenesis"},{"issue":"3\u20134","key":"5748_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/ars.2006.8.395","volume":"8","author":"G Scapagnini","year":"2006","unstructured":"Scapagnini G, Colombrita C, Amadio M, D\u2019Agata V, Arcelli E, Sapienza M, Quattrone A, Calabrese V (2006) Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid Redox Signal 8(3\u20134):395\u2013403. https:\/\/doi.org\/10.1089\/ars.2006.8.395","journal-title":"Antioxid Redox Signal"},{"issue":"Pt 3","key":"5748_CR55","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1042\/bj20021619","volume":"371","author":"E Balogun","year":"2003","unstructured":"Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R, Alam J, Motterlini R (2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371(Pt 3):887\u2013895. https:\/\/doi.org\/10.1042\/bj20021619","journal-title":"Biochem J"},{"issue":"1","key":"5748_CR56","first-page":"165","volume":"19","author":"SJ McNally","year":"2007","unstructured":"McNally SJ, Harrison EM, Ross JA, Garden OJ, Wigmore SJ (2007) Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med 19(1):165\u2013172","journal-title":"Int J Mol Med"},{"issue":"3","key":"5748_CR57","doi-asserted-by":"publisher","first-page":"E443","DOI":"10.1208\/aapsj080352","volume":"8","author":"RL Thangapazham","year":"2006","unstructured":"Thangapazham RL, Sharma A, Maheshwari RK (2006) Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 8(3):E443-449. https:\/\/doi.org\/10.1208\/aapsj080352","journal-title":"AAPS J"},{"key":"5748_CR58","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cbi.2019.01.010","volume":"305","author":"J Xu","year":"2019","unstructured":"Xu J, Zhou L, Weng Q, Xiao L, Li Q (2019) Curcumin analogues attenuate A\u03b2(25\u201335)-induced oxidative stress in PC12 cells via Keap1\/Nrf2\/HO-1 signaling pathways. Chem Biol Interact 305:171\u2013179. https:\/\/doi.org\/10.1016\/j.cbi.2019.01.010","journal-title":"Chem Biol Interact"},{"key":"5748_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103274","volume":"56","author":"M Petracca","year":"2021","unstructured":"Petracca M, Quarantelli M, Moccia M, Vacca G, Satelliti B, D\u2019Ambrosio G, Carotenuto A, Ragucci M et al (2021) Prospective study to evaluate efficacy, safety and tolerability of dietary supplement of Curcumin (BCM95) in subjects with active relapsing Multiple Sclerosis treated with subcutaneous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial. Mult Scler Relat Disord 56:103274. https:\/\/doi.org\/10.1016\/j.msard.2021.103274","journal-title":"Mult Scler Relat Disord"},{"key":"5748_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/nu18020317","author":"L Niu","year":"2026","unstructured":"Niu L, Luo Y, Xie W, Wang C, Liu Z (2026) Dietary (-)-Epigallocatechin gallate (EGCG): state-of-the-art advances in bioactivities, bioavailability enhancement strategies, and applications in nutrition and health. Nutrients. https:\/\/doi.org\/10.3390\/nu18020317","journal-title":"Nutrients"},{"issue":"Suppl","key":"5748_CR61","doi-asserted-by":"publisher","first-page":"492s","DOI":"10.1080\/07315724.2009.10718116","volume":"28","author":"L Romeo","year":"2009","unstructured":"Romeo L, Intrieri M, D\u2019Agata V, Mangano NG, Oriani G, Ontario ML, Scapagnini G (2009) The major green tea polyphenol, (-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. J Am Coll Nutr 28(Suppl):492s\u2013499s. https:\/\/doi.org\/10.1080\/07315724.2009.10718116","journal-title":"J Am Coll Nutr"},{"issue":"10","key":"5748_CR62","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.11817\/j.issn.1672-7347.2018.10.001","volume":"43","author":"F He","year":"2018","unstructured":"He F, Zhang Y, Chen S, Ye B, Chen J, Li C (2018) Effect of EGCG on oxidative stress and Nrf2\/HO-1 pathway in neurons exposed to oxygen-glucose deprivation\/reperfusion. Zhong Nan Da Xue Xue Bao Yi Xue Ban 43(10):1041\u20131047. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2018.10.001","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"5748_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23074004","author":"SR Kim","year":"2022","unstructured":"Kim SR, Seong KJ, Kim WJ, Jung JY (2022) Epigallocatechin gallate protects against hypoxia-induced inflammation in microglia via NF-\u03baB suppression and Nrf-2\/HO-1 activation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23074004","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5748_CR64","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.abb.2008.04.003","volume":"476","author":"HK Na","year":"2008","unstructured":"Na HK, Kim EH, Jung JH, Lee HH, Hyun JW, Surh YJ (2008) (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch Biochem Biophys 476(2):171\u2013177. https:\/\/doi.org\/10.1016\/j.abb.2008.04.003","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"5748_CR65","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1039\/c7fo01554b","volume":"9","author":"Y Mi","year":"2018","unstructured":"Mi Y, Zhang W, Tian H, Li R, Huang S, Li X, Qi G, Liu X (2018) EGCG evokes Nrf2 nuclear translocation and dampens PTP1B expression to ameliorate metabolic misalignment under insulin resistance condition. Food Funct 9(3):1510\u20131523. https:\/\/doi.org\/10.1039\/c7fo01554b","journal-title":"Food Funct"},{"issue":"3","key":"5748_CR66","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.yexmp.2014.10.004","volume":"97","author":"N Liu","year":"2014","unstructured":"Liu N, Kan QC, Zhang XJ, Xv YM, Zhang S, Zhang GX, Zhu L (2014) Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis. Exp Mol Pathol 97(3):470\u2013476. https:\/\/doi.org\/10.1016\/j.yexmp.2014.10.004","journal-title":"Exp Mol Pathol"},{"key":"5748_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105211","volume":"151","author":"A Khan","year":"2021","unstructured":"Khan A, Shal B, Khan AU, Bibi T, Islam SU, Baig MW, Haq IU, Ali H et al (2021) Withametelin, a novel phytosterol, alleviates neurological symptoms in EAE mouse model of multiple sclerosis via modulation of Nrf2\/HO-1 and TLR4\/NF-\u03baB signaling. Neurochem Int 151:105211. https:\/\/doi.org\/10.1016\/j.neuint.2021.105211","journal-title":"Neurochem Int"},{"issue":"11","key":"5748_CR68","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1007\/s12035-021-02497-5","volume":"58","author":"R Nasrnezhad","year":"2021","unstructured":"Nasrnezhad R, Halalkhor S, Sadeghi F, Pourabdolhossein F (2021) Piperine improves experimental autoimmune encephalomyelitis (EAE) in Lewis rats through its neuroprotective, anti-inflammatory, and antioxidant effects. Mol Neurobiol 58(11):5473\u20135493. https:\/\/doi.org\/10.1007\/s12035-021-02497-5","journal-title":"Mol Neurobiol"},{"key":"5748_CR69","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.expneurol.2013.10.002","volume":"250","author":"B Li","year":"2013","unstructured":"Li B, Cui W, Liu J, Li R, Liu Q, Xie XH, Ge XL, Zhang J et al (2013) Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice. Exp Neurol 250:239\u2013249. https:\/\/doi.org\/10.1016\/j.expneurol.2013.10.002","journal-title":"Exp Neurol"},{"key":"5748_CR70","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04648-0","author":"A Devi","year":"2025","unstructured":"Devi A, Kabra A, Saeedan AS, Ansari MN (2025) Exploring myricetin: a comprehensive review of its pharmacological potential, formulation strategies, and clinical outlook. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04648-0","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"5748_CR71","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.3390\/cimb46060335","volume":"46","author":"G Tancreda","year":"2024","unstructured":"Tancreda G, Ravera S, Panfoli I (2024) Exploring the therapeutic potential: bioactive molecules and dietary interventions in multiple sclerosis management. Curr Issues Mol Biol 46(6):5595\u20135613. https:\/\/doi.org\/10.3390\/cimb46060335","journal-title":"Curr Issues Mol Biol"},{"key":"5748_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.936632","volume":"13","author":"Y Song","year":"2022","unstructured":"Song Y, Wang M, Zhao S, Tian Y, Zhang C (2022) Matrine promotes mitochondrial biosynthesis and reduces oxidative stress in experimental optic neuritis. Front Pharmacol 13:936632. https:\/\/doi.org\/10.3389\/fphar.2022.936632","journal-title":"Front Pharmacol"},{"issue":"10","key":"5748_CR73","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1039\/c6fo00825a","volume":"7","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Li Z, Wu S, Li X, Sang Y, Li J, Niu Y, Ding H (2016) Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway. Food Funct 7(10):4332\u20134342. https:\/\/doi.org\/10.1039\/c6fo00825a","journal-title":"Food Funct"},{"issue":"12","key":"5748_CR74","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1158\/1940-6207.Capr-14-0127","volume":"7","author":"TO Khor","year":"2014","unstructured":"Khor TO, Fuentes F, Shu L, Paredes-Gonzalez X, Yang AY, Liu Y, Smiraglia DJ, Yegnasubramanian S et al (2014) Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer. Cancer Prev Res Phila 7(12):1186\u20131197. https:\/\/doi.org\/10.1158\/1940-6207.Capr-14-0127","journal-title":"Cancer Prev Res Phila"},{"key":"5748_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2018.01.046","volume":"824","author":"F Zhao","year":"2018","unstructured":"Zhao F, Zhang J, Chang N (2018) Epigenetic modification of Nrf2 by sulforaphane increases the antioxidative and anti-inflammatory capacity in a cellular model of Alzheimer\u2019s disease. Eur J Pharmacol 824:1\u201310. https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.046","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5748_CR76","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/1566524019666191016150757","volume":"20","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Ahmadi Z, Mohammadinejad R, Farkhondeh T, Samarghandian S (2020) Curcumin activates the Nrf2 pathway and induces cellular protection against oxidative injury. Curr Mol Med 20(2):116\u2013133. https:\/\/doi.org\/10.2174\/1566524019666191016150757","journal-title":"Curr Mol Med"},{"key":"5748_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117671","volume":"253","author":"H Roshanbakhsh","year":"2020","unstructured":"Roshanbakhsh H, Elahdadi Salmani M, Dehghan S, Nazari A, Javan M, Pourabdolhossein F (2020) Piperine ameliorated memory impairment and myelin damage in lysolecethin induced hippocampal demyelination. Life Sci 253:117671. https:\/\/doi.org\/10.1016\/j.lfs.2020.117671","journal-title":"Life Sci"},{"key":"5748_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150651","volume":"735","author":"F Feng","year":"2024","unstructured":"Feng F, Li X, Wang W, Dou M, Li S, Jin X, Chu Y, Zhu L (2024) Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis. Biochem Biophys Res Commun 735:150651. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150651","journal-title":"Biochem Biophys Res Commun"},{"key":"5748_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9090865","author":"S Bhattacharjee","year":"2020","unstructured":"Bhattacharjee S, Dashwood RH (2020) Epigenetic regulation of NRF2\/KEAP1 by phytochemicals. Antioxidants. https:\/\/doi.org\/10.3390\/antiox9090865","journal-title":"Antioxidants"},{"issue":"1","key":"5748_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02491-z","volume":"11","author":"X Yang","year":"2025","unstructured":"Yang X, Liu Y, Cao J, Wu C, Tang L, Bian W, Chen Y, Yu L et al (2025) Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment. Cell Death Discov 11(1):189. https:\/\/doi.org\/10.1038\/s41420-025-02491-z","journal-title":"Cell Death Discov"},{"key":"5748_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117245","volume":"285","author":"F Moraca","year":"2025","unstructured":"Moraca F, Arciuolo V, Marzano S, Napolitano F, Castellano G, D\u2019Aria F, Di Porzio A, Landolfi L et al (2025) Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer. Eur J Med Chem 285:117245. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117245","journal-title":"Eur J Med Chem"},{"key":"5748_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162482","author":"F Napolitano","year":"2022","unstructured":"Napolitano F, Di Somma S, Castellano G, Amato J, Pagano B, Randazzo A, Portella G, Malfitano AM (2022) Combination of dl922-947 oncolytic adenovirus and G-quadruplex binders uncovers improved antitumor activity in breast cancer. Cells. https:\/\/doi.org\/10.3390\/cells11162482","journal-title":"Cells"},{"key":"5748_CR83","doi-asserted-by":"publisher","unstructured":"Di Somma S, Amato J, Iaccarino N, Pagano B, Randazzo A, Portella G, Malfitano AM (2019) G-quadruplex binders induce immunogenic cell death markers in aggressive breast cancer cells. Cancers (Basel) 11(11). https:\/\/doi.org\/10.3390\/cancers11111797","DOI":"10.3390\/cancers11111797"},{"key":"5748_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.688086","volume":"8","author":"M Milo\u0161evi\u0107","year":"2021","unstructured":"Milo\u0161evi\u0107 M, Arsi\u0107 A, Cvetkovi\u0107 Z, Vu\u010di\u0107 V (2021) Memorable food: fighting age-related neurodegeneration by precision nutrition. Front Nutr 8:688086. https:\/\/doi.org\/10.3389\/fnut.2021.688086","journal-title":"Front Nutr"},{"issue":"1","key":"5748_CR85","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12974-020-02020-y","volume":"17","author":"M Chen","year":"2020","unstructured":"Chen M, Yang LL, Hu ZW, Qin C, Zhou LQ, Duan YL, Bosco DB, Wu LJ et al (2020) Deficiency of microglial Hv1 channel is associated with activation of autophagic pathway and ROS production in LPC-induced demyelination mouse model. J Neuroinflammation 17(1):333. https:\/\/doi.org\/10.1186\/s12974-020-02020-y","journal-title":"J Neuroinflammation"},{"key":"5748_CR86","doi-asserted-by":"publisher","unstructured":"Moruno-Manchon JF, Lejault P, Wang Y, McCauley B, Honarpisheh P, Morales Scheihing DA, Singh S, Dang W, et al. (2020) Small-molecule G-quadruplex stabilizers reveal a novel pathway of autophagy regulation in neurons. Elife 9. https:\/\/doi.org\/10.7554\/eLife.52283","DOI":"10.7554\/eLife.52283"},{"key":"5748_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12030771","author":"K Rubio","year":"2023","unstructured":"Rubio K, Hern\u00e1ndez-Cruz EY, Rogel-Ayala DG, Sarvari P, Isidoro C, Barreto G, Pedraza-Chaverri J (2023) Nutriepigenomics in environmental-associated oxidative stress. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12030771","journal-title":"Antioxidants"},{"issue":"1","key":"5748_CR88","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbrc.2014.03.117","volume":"447","author":"ZA Waller","year":"2014","unstructured":"Waller ZA, Howell LA, Macdonald CJ, O\u2019Connell MA, Searcey M (2014) Identification and characterisation of a G-quadruplex forming sequence in the promoter region of nuclear factor (erythroid-derived 2)-like 2 (Nrf2). Biochem Biophys Res Commun 447(1):128\u2013132. https:\/\/doi.org\/10.1016\/j.bbrc.2014.03.117","journal-title":"Biochem Biophys Res Commun"},{"key":"5748_CR89","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00122-16","author":"SC Lee","year":"2017","unstructured":"Lee SC, Zhang J, Strom J, Yang D, Dinh TN, Kappeler K, Chen QM (2017) G-quadruplex in the NRF2 mRNA 5\u2019 untranslated region regulates de novo NRF2 protein translation under oxidative stress. Mol Cell Biol. https:\/\/doi.org\/10.1128\/mcb.00122-16","journal-title":"Mol Cell Biol"},{"key":"5748_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2025.108548","volume":"796","author":"AM Malfitano","year":"2025","unstructured":"Malfitano AM, Castellano G, Croce A, Napolitano F, Portella G, Beguinot F, Formisano P, Fiory F (2025) Nutritional bioactive compounds with beneficial effects for multiple sclerosis: potential implication of G-Quadruplexes? Mutat Res Rev Mutat Res 796:108548. https:\/\/doi.org\/10.1016\/j.mrrev.2025.108548","journal-title":"Mutat Res Rev Mutat Res"},{"key":"5748_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/srep39239","volume":"6","author":"A Tawani","year":"2016","unstructured":"Tawani A, Amanullah A, Mishra A, Kumar A (2016) Evidences for piperine inhibiting cancer by targeting human G-quadruplex DNA sequences. Sci Rep 6:39239. https:\/\/doi.org\/10.1038\/srep39239","journal-title":"Sci Rep"},{"issue":"2","key":"5748_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127825","volume":"254","author":"H Ye","year":"2024","unstructured":"Ye H, Zhang H, Xiang J, Shen G, Yang F, Wang F, Wang J, Tang Y (2024) Advances and prospects of natural dietary polyphenols as G-quadruplex stabilizers in biomedical applications. Int J Biol Macromol 254(2):127825. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127825","journal-title":"Int J Biol Macromol"},{"key":"5748_CR93","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/681289","volume":"2015","author":"M Storoni","year":"2015","unstructured":"Storoni M, Plant GT (2015) The therapeutic potential of the ketogenic diet in treating progressive multiple sclerosis. Mult Scler Int 2015:681289. https:\/\/doi.org\/10.1155\/2015\/681289","journal-title":"Mult Scler Int"},{"key":"5748_CR94","doi-asserted-by":"publisher","unstructured":"Benlloch M, L\u00f3pez-Rodr\u00edguez MM, Cuerda-Ballester M, Drehmer E, Carrera S, Ceron JJ, Tvarijonaviciute A, Chirivella J, et al. (2019) Satiating effect of a ketogenic diet and its impact on muscle improvement and oxidation state in multiple sclerosis patients. Nutrients 11 (5). https:\/\/doi.org\/10.3390\/nu11051156","DOI":"10.3390\/nu11051156"},{"issue":"4","key":"5748_CR95","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000565","volume":"6","author":"JN Brenton","year":"2019","unstructured":"Brenton JN, Banwell B, Bergqvist AGC, Lehner-Gulotta D, Gampper L, Leytham E, Coleman R, Goldman MD (2019) Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm 6(4):e565. https:\/\/doi.org\/10.1212\/nxi.0000000000000565","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"5748_CR96","doi-asserted-by":"publisher","unstructured":"Ordo\u00f1ez-Rodriguez A, Roman P, Rueda-Ruzafa L, Campos-Rios A, Cardona D (2023) Changes in gut microbiota and multiple sclerosis: a systematic review. Int J Environ Res Public Health 20(5). https:\/\/doi.org\/10.3390\/ijerph20054624","DOI":"10.3390\/ijerph20054624"},{"key":"5748_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01141","volume":"8","author":"A Swidsinski","year":"2017","unstructured":"Swidsinski A, D\u00f6rffel Y, Loening-Baucke V, Gille C, G\u00f6ktas \u00d6, Rei\u00dfhauer A, Neuhaus J, Weylandt KH et al (2017) Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet. Front Microbiol 8:1141. https:\/\/doi.org\/10.3389\/fmicb.2017.01141","journal-title":"Front Microbiol"},{"key":"5748_CR98","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.mad.2014.01.002","volume":"136","author":"DC Willcox","year":"2014","unstructured":"Willcox DC, Scapagnini G, Willcox BJ (2014) Healthy aging diets other than the Mediterranean: a focus on the Okinawan diet. Mech Ageing Dev 136:148\u2013162. https:\/\/doi.org\/10.1016\/j.mad.2014.01.002","journal-title":"Mech Ageing Dev"},{"key":"5748_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1746176","volume":"12","author":"M Hao","year":"2025","unstructured":"Hao M, Tan X, Liu K, Xin N (2025) Nanoencapsulation of nutraceuticals: enhancing stability and bioavailability in functional foods. Front Nutr 12:1746176. https:\/\/doi.org\/10.3389\/fnut.2025.1746176","journal-title":"Front Nutr"},{"issue":"5","key":"5748_CR100","doi-asserted-by":"publisher","first-page":"563","DOI":"10.18502\/ijaai.v24i5.19740","volume":"24","author":"M Aliyu","year":"2025","unstructured":"Aliyu M, Saboor-Yaraghi AA, Sahraian MA, Noorbakhsh F (2025) The experimental autoimmune encephalomyelitis (EAE) model: a gateway to successful translation of multiple sclerosis therapies. Iran J Allergy Asthma Immunol 24(5):563\u2013580. https:\/\/doi.org\/10.18502\/ijaai.v24i5.19740","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"1","key":"5748_CR101","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/archneurpsyc.1953.02320250097011","volume":"69","author":"RL Swank","year":"1953","unstructured":"Swank RL (1953) Treatment of multiple sclerosis with low-fat diet. AMA Arch Neurol Psychiatry 69(1):91\u2013103. https:\/\/doi.org\/10.1001\/archneurpsyc.1953.02320250097011","journal-title":"AMA Arch Neurol Psychiatry"},{"issue":"5","key":"5748_CR102","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/acm.2013.0188","volume":"20","author":"B Bisht","year":"2014","unstructured":"Bisht B, Darling WG, Grossmann RE, Shivapour ET, Lutgendorf SK, Snetselaar LG, Hall MJ, Zimmerman MB et al (2014) A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue. J Altern Complement Med 20(5):347\u2013355. https:\/\/doi.org\/10.1089\/acm.2013.0188","journal-title":"J Altern Complement Med"},{"key":"5748_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/dnnd.S116949","volume":"7","author":"AK Irish","year":"2017","unstructured":"Irish AK, Erickson CM, Wahls TL, Snetselaar LG, Darling WG (2017) Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study. Degener Neurol Neuromuscul Dis 7:1\u201318. https:\/\/doi.org\/10.2147\/dnnd.S116949","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"3","key":"5748_CR104","first-page":"135","volume":"43","author":"Z Dean","year":"2022","unstructured":"Dean Z, Penesova A, Radikova Z, Dean Z, Kollar B (2022) Pilot study of longterm low fat diet in relapsing-remitting multiple sclerosis. Neuro Endocrinol Lett 43(3):135\u2013139","journal-title":"Neuro Endocrinol Lett"},{"issue":"2","key":"5748_CR105","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s0899-9007(02)00851-1","volume":"19","author":"RL Swank","year":"2003","unstructured":"Swank RL, Goodwin J (2003) Review of MS patient survival on a Swank low saturated fat diet. Nutrition 19(2):161\u2013162. https:\/\/doi.org\/10.1016\/s0899-9007(02)00851-1","journal-title":"Nutrition"},{"key":"5748_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102315","author":"U Ha\u00df","year":"2019","unstructured":"Ha\u00df U, Herpich C, Norman K (2019) Anti-inflammatory diets and fatigue. Nutrients. https:\/\/doi.org\/10.3390\/nu11102315","journal-title":"Nutrients"},{"issue":"11","key":"5748_CR107","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1080\/1028415x.2022.2128010","volume":"26","author":"AR Moravejolahkami","year":"2023","unstructured":"Moravejolahkami AR, Chitsaz A, Hassanzadeh A, Paknahad Z (2023) Effects of anti-inflammatory-antioxidant-rich diet and co-supplemented synbiotics intervention in patients with progressive forms of multiple sclerosis: a single-center, single-blind randomized clinical trial. Nutr Neurosci 26(11):1078\u20131089. https:\/\/doi.org\/10.1080\/1028415x.2022.2128010","journal-title":"Nutr Neurosci"},{"issue":"9","key":"5748_CR108","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/13524585231181841","volume":"29","author":"L Alfredsson","year":"2023","unstructured":"Alfredsson L, Olsson T, Hedstr\u00f6m AK (2023) Inverse association between Mediterranean diet and risk of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 29(9):1118\u20131125. https:\/\/doi.org\/10.1177\/13524585231181841","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)"},{"key":"5748_CR109","doi-asserted-by":"publisher","first-page":"101403","DOI":"10.1016\/j.msard.2019.101403","volume":"36","author":"I Katz Sand","year":"2019","unstructured":"Katz Sand I, Benn EKT, Fabian M, Fitzgerald KC, Digga E, Deshpande R, Miller A, Gallo S et al (2019) Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: a pilot study. Multiple Sclerosis Relat Disord 36:101403. https:\/\/doi.org\/10.1016\/j.msard.2019.101403","journal-title":"Multiple Sclerosis Relat Disord"},{"issue":"3","key":"5748_CR110","doi-asserted-by":"publisher","first-page":"112","DOI":"10.18502\/cjn.v19i3.5424","volume":"19","author":"S Razeghi-Jahromi","year":"2020","unstructured":"Razeghi-Jahromi S, Doosti R, Ghorbani Z, Saeedi R, Abolhasani M, Akbari N, Cheraghi-Serkani F, Moghadasi AN et al (2020) A randomized controlled trial investigating the effects of a mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue. Curr J Neurol 19(3):112\u2013121. https:\/\/doi.org\/10.18502\/cjn.v19i3.5424","journal-title":"Curr J Neurol"},{"issue":"1","key":"5748_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s40795-025-01156-5","volume":"11","author":"LS Bahr","year":"2025","unstructured":"Bahr LS, Bellmann-Strobl J, Koppold DA, Rust R, Schmitz-H\u00fcbsch T, Olszewska M, Stadlbauer J, Bock M et al (2025) Fasting, ketogenic, and anti-inflammatory diets in multiple sclerosis: a randomized controlled trial with 18-month follow-up. BMC Nutr 11(1):167. https:\/\/doi.org\/10.1186\/s40795-025-01156-5","journal-title":"BMC Nutr"},{"issue":"7","key":"5748_CR112","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1080\/1028415x.2024.2425649","volume":"28","author":"S Keramatzadeh","year":"2025","unstructured":"Keramatzadeh S, Hosseini SA, Majdinasab N, Cheraghian B, Zilaee M (2025) Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial. Nutr Neurosci 28(7):854\u2013862. https:\/\/doi.org\/10.1080\/1028415x.2024.2425649","journal-title":"Nutr Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05748-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05748-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05748-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T03:18:26Z","timestamp":1771384706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05748-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5748"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05748-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"450"}}